Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Retained Earnings (2016 - 2025)

Historic Retained Earnings for BioRestorative Therapies (BRTX) over the last 15 years, with Q3 2025 value amounting to -$166.7 million.

  • BioRestorative Therapies' Retained Earnings fell 822.53% to -$166.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$166.7 million, marking a year-over-year decrease of 822.53%. This contributed to the annual value of -$155.7 million for FY2024, which is 612.09% down from last year.
  • As of Q3 2025, BioRestorative Therapies' Retained Earnings stood at -$166.7 million, which was down 822.53% from -$163.7 million recorded in Q2 2025.
  • In the past 5 years, BioRestorative Therapies' Retained Earnings registered a high of -$105.5 million during Q1 2021, and its lowest value of -$166.7 million during Q3 2025.
  • For the 5-year period, BioRestorative Therapies' Retained Earnings averaged around -$141.0 million, with its median value being -$144.4 million (2023).
  • Its Retained Earnings has fluctuated over the past 5 years, first crashed by 4931.2% in 2021, then plummeted by 159.19% in 2022.
  • Quarter analysis of 5 years shows BioRestorative Therapies' Retained Earnings stood at -$134.1 million in 2021, then decreased by 1.59% to -$136.3 million in 2022, then fell by 7.64% to -$146.7 million in 2023, then fell by 6.12% to -$155.7 million in 2024, then decreased by 7.09% to -$166.7 million in 2025.
  • Its Retained Earnings stands at -$166.7 million for Q3 2025, versus -$163.7 million for Q2 2025 and -$161.0 million for Q1 2025.